VR Logo

Raymed Labs Ltd. download report


Healthcare | Drugs & Pharma

Raymed Labs Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2020 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2019 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2018 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2017 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2016 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2015 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2014 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2013 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2012 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2011 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
2010 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes
1999 Raymed Labs Ltd. Annual Report Raymed Labs Ltd. chairman speech Raymed Labs Ltd. director's report Raymed Labs Ltd. management discussion Raymed Labs Ltd. corporate governance Raymed Labs Ltd. auditor's report Raymed Labs Ltd. account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1992

Chairman: --

Managing Director: --

Listing: BSE: 531207

Country: India

Headquarters: Noida, Uttar Pradesh

Website: www.raymedlab.com

Key Facts

Market cap: ₹0.74 Cr

Revenue (TTM): ₹0.00 Cr

Earnings (TTM): ₹-0.08 Cr

Cash: ₹0.00 Cr

Total Debt: ₹2.16 Cr

Promoters' ownership: 28.36%

Liquidity: Low

52 Week range: ₹0.92 - 1.73

Face value: ₹10.00

Shares outstanding: 42,73,500

10 Years Aggregate:

  • CFO: ₹0.07 Cr
  • EBITDA: ₹-0.36 Cr
  • Net Profit: ₹-0.52 Cr

Stock Performance

Time Period Raymed Labs S&P BSE Healthcare* S&P BSE Small Cap*
YTD64.76-17.34-15.40
1 month4.85-3.61-2.73
3 months---10.54-9.88
1 Year86.02-14.59-0.76
3 Years--18.8920.51
5 Years-7.829.1310.45
10 Years-24.6012.3514.46
As on 30-May-2022 *As on 29-Jun-2022
Year Raymed Labs S&P BSE Small Cap S&P BSE Healthcare
2015-60.166.7615.06
2014-51.8469.2447.43